Aluminum, NO, and nerve growth factor neurotoxicity in cholinergic neurons.
Several neurotoxic compounds, including Al, NO, and beta-amyloid may contribute to the impairment or loss of brain cholinergic neurons in the course of various neurodegenerative diseases. Genotype and phenotypic modifications of cholinergic neurons may determine their variable functional competency and susceptibility to reported neurotoxic insults. Hybrid, immortalized SN56 cholinergic cells from mouse septum may serve as a model for in vitro cholinotoxicity studies. Differentiation by various combinations of cAMP, retinoic acid, and nerve growth factor may provide cells of different morphologic maturity as well as activities of acetylcholine and acetyl-CoA metabolism. In general, differentiated cells appear to be more susceptible to neurotoxic signals than the non-differentiated ones, as evidenced by loss of sprouting and connectivity, decreases in choline acetyltransferase and pyruvate dehydrogenase activities, disturbances in acetyl-CoA compartmentation and metabolism, insufficient or excessive acetylcholine release, as well as increased expression of apoptosis markers. Each neurotoxin impaired both acetylcholine and acetyl-CoA metabolism of these cells. Activation of p75 or trkA receptors made either acetyl-CoA or cholinergic metabolism more susceptible to neurotoxic influences, respectively. Neurotoxins aggravated detrimental effects of each other, particularly in differentiated cells. Thus brain cholinergic neurons might display a differential susceptibility to Al and other neurotoxins depending on their genotype or phenotype-dependent variability of the cholinergic and acetyl-CoA metabolism.
Szutowicz
A
A
Chair of Clinical Biochemistry, Department of Laboratory Medicine, Medical University of Gdańsk, Debinki 7, 80-211 Gdańsk, Poland. aszut@amg.gda.pl
D000105:Acetyl Coenzyme A / Q000378:metabolism*; D000109:Acetylcholine / Q000378:metabolism*; D000535:Aluminum / Q000633:toxicity; D016229:Amyloid beta-Peptides / Q000633:toxicity; D000818:Animals; D002454:Cell Differentiation / Q000187:drug effects* / Q000502:physiology; D006801:Humans; D020932:Nerve Growth Factor / Q000633:toxicity; D019636:Neurodegenerative Diseases / Q000139:chemically induced / Q000378:metabolism* / Q000503:physiopathology; D009474:Neurons / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology; D009498:Neurotoxins / Q000633:toxicity*; D009569:Nitric Oxide / Q000494:pharmacology
D016229:Amyloid beta-Peptides; D009498:Neurotoxins; D009569:Nitric Oxide; D000105:Acetyl Coenzyme A; D020932:Nerve Growth Factor; D000535:Aluminum; D000109:Acetylcholine